Patient-Reported Outcome in metastatic breast cancer and platinum-resistant recurrent ovarian cancer patients treated with metronomic cyclophosphamide ± methotrexate: PROmetronomic
{{output}}
Introduction: Maintenance of subjective well-being and health-related quality of life (HRQoL) play a crucial role in the treatment of metastatic cancer. The metronomic chemotherapy (MCT) may be a favorable treatment option in met... ...
